during the rapidly evolving discipline of oncology analysis, correct and successful mutation screening is crucial for creating qualified therapies. The KRAS solutions Platform plays a pivotal part On this landscape by providing in depth remedies for KRAS mutation profiling and Investigation. KRAS mutations, present in somewhere around ninety five%